The non immunogenicity of CALLA in leukemic children.
The sera from 55 children with acute lymphoblastic leukemia (ALL) treated with active immunotherapy were examined for the presence of antibodies against common ALL antigen (CALLA). A solid phase indirect radioimmunometric assay (IRA) was developed which enabled the detection of anti-CALLA antibody in patients' sera, utilizing the ability of affinity-purified CALLA to bind Ricinus communis agglutinin and anti-CALLA antibody simultaneously. Using IRA, anti-CALLA antibody activity could not be detected in a majority of patients. We concluded that the patients did not raise comparable antibodies against CALLA, indicating this antigen is not immunogenic for ALL patients.
Komada
Y
Y
Department of Pediatrics, Mie University School of Medicine, Japan.
Yamamoto
H
H
Azuma
E
E
Tanaka
S
S
Kamiya
H
H
Sakurai
M
M
D000912:Antibodies, Neoplasm / Q000276:immunology*; D000943:Antigens, Differentiation / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D002648:Child; D006801:Humans; D007167:Immunotherapy; D015260:Neprilysin; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology* / Q000628:therapy; D011863:Radioimmunoassay
D000912:Antibodies, Neoplasm; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D015260:Neprilysin